title: Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy.
authors: R
authors: R
authors: Musso
authors: A
authors: A
authors: Longo
authors: A
authors: A
authors: Triolo
authors: R
authors: R
authors: Giustolisi
authors: R R
authors: RR
authors: Cacciola
authors: E
authors: E
authors: Cacciola
authors: R
authors: R
authors: Vecchio
authors: A
authors: A
authors: Russo
authors: A
authors: A
authors: Magnano
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D006801:Humans; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000494:pharmacology*; D012597:Sclerosing Solutions / Q000627:therapeutic use*
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols